Tharimmune

Biotechnology company(THAR)

Acerca de Tharimmune

Tharimmune, Inc. (THAR) is a clinical-stage biotechnology company developing a portfolio of therapeutic candidates for inflammation and immunology.
Comunidad
Website
Etiquetas
Digital Asset Treasury
Publicly listed company
Crypto Stocks

Tendencia de cambio del índice de popularidad

Sin registro

Miembros del equipo

Mark Wendland
Mark Wendland

Chairman and CEO

Angela Radkowski
Angela Radkowski

COO

Inversores

Liberty City Ventures
Liberty City Ventures
DRW Venture Capital
DRW Venture Capital
Kraken
Kraken
Polychain
Polychain
ARK Invest
ARK Invest

Detalles de la recaudación de fondos

Post-IPO(2025-11-03)
Cantidad€475,30M
Inversores
Liberty City Ventures
Liberty City Ventures
DRW Venture Capital
DRW Venture Capital
Kraken
Kraken
Polychain
Polychain
ARK Invest
ARK Invest
Valuación--